Navigation

Investiment.io
Financial analysis platform

Thermo Fisher Scientific Inc.

TMO โ€ข NYSE

$691.33
โ–ผ8.89 (1.27%)โ€ข REGULAR

Thermo Fisher Scientific Inc.

$691.33
โ–ผ1.3%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ง

Cash Flow StatementTMO

Cash Flow Summary

Key cash flow metrics and liquidity indicators for TMO

๐Ÿ”„
Operating Cash Flow
$7,818,000
(in thousands)
๐Ÿ’ฐ
Free Cash Flow
$6,293,000
(in thousands)
๐Ÿ—๏ธ
Capital Expenditures
-$1,525,000
(in thousands)
๐Ÿ“ˆ
Net Change in Cash
$5,839,000
(in thousands)

Cash Flow Analysis

Analyze operating, investing, and financing cash flows over time

Period:annual

Select Metrics to Compare (4 selected)

Net Operating Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$2.50B$5.00B$7.50B$10.00B-12%-8%-4%0%+4%
  • Net Operating Cash Flow
  • Net Operating Cash Flow YoY Growth

Free Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$2.00B$4.00B$6.00B$8.00B-15%-10%-5%0%+5%
  • Free Cash Flow
  • Free Cash Flow YoY Growth

Capital Expenditures Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-2.80B$-2.45B$-2.10B$-1.75B$-1.40B-15%0%+15%+30%+45%
  • Capital Expenditures
  • Capital Expenditures YoY Growth

Net Change in Cash Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-6.00B$-3.00B$0.00K$3.00B$6.00B-900%-600%-300%0%+300%
  • Net Change in Cash
  • Net Change in Cash YoY Growth